Titre : Nucléosomes

Nucléosomes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Microarray Analysis

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment identifier les nucléosomes dans une cellule ?

Les nucléosomes peuvent être identifiés par des techniques comme l'électrophorèse sur gel.
Nucléosomes Électrophorèse ADN
#2

Quels tests détectent les niveaux de nucléosomes ?

Des tests sanguins mesurant les niveaux de nucléosomes libres sont utilisés en clinique.
Nucléosomes Tests sanguins Biomarqueurs

Symptômes 2

#1

Les nucléosomes sont-ils associés à des symptômes ?

Les nucléosomes eux-mêmes ne causent pas de symptômes, mais leur dysfonction peut être liée à des maladies.
Nucléosomes Maladies Dysfonction
#2

Quels troubles sont liés aux anomalies des nucléosomes ?

Des anomalies des nucléosomes sont associées à des cancers et des maladies auto-immunes.
Nucléosomes Cancers Maladies auto-immunes

Prévention 2

#1

Peut-on prévenir les anomalies des nucléosomes ?

Une alimentation saine et un mode de vie actif peuvent réduire le risque de maladies associées.
Nucléosomes Prévention Mode de vie
#2

Y a-t-il des dépistages pour les problèmes de nucléosomes ?

Actuellement, il n'existe pas de dépistage spécifique pour les anomalies des nucléosomes.
Nucléosomes Dépistage Anomalies

Traitements 2

#1

Comment traiter les maladies liées aux nucléosomes ?

Le traitement dépend de la maladie sous-jacente, incluant chimiothérapie ou immunothérapie.
Nucléosomes Chimiothérapie Immunothérapie
#2

Les médicaments ciblent-ils les nucléosomes ?

Certains médicaments visent les voies de signalisation affectées par les nucléosomes.
Nucléosomes Médicaments Voies de signalisation

Complications 2

#1

Quelles complications peuvent survenir avec des nucléosomes anormaux ?

Des nucléosomes anormaux peuvent entraîner des cancers et des troubles immunitaires.
Nucléosomes Complications Cancers
#2

Les nucléosomes affectent-ils la réparation de l'ADN ?

Oui, des anomalies dans les nucléosomes peuvent perturber les mécanismes de réparation de l'ADN.
Nucléosomes Réparation de l'ADN Anomalies

Facteurs de risque 2

#1

Quels facteurs augmentent le risque d'anomalies des nucléosomes ?

Des facteurs comme l'exposition à des toxines et des prédispositions génétiques augmentent le risque.
Nucléosomes Facteurs de risque Toxines
#2

L'âge influence-t-il les nucléosomes ?

Oui, le vieillissement peut affecter la structure et la fonction des nucléosomes.
Nucléosomes Âge Vieillissement
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nucléosomes : Questions médicales les plus fréquentes", "headline": "Nucléosomes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nucléosomes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-14", "dateModified": "2026-03-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nucléosomes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Chromatine", "url": "https://questionsmedicales.fr/mesh/D002843", "about": { "@type": "MedicalCondition", "name": "Chromatine", "code": { "@type": "MedicalCode", "code": "D002843", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "G05.360.160.180" } } }, "about": { "@type": "MedicalCondition", "name": "Nucléosomes", "alternateName": "Nucleosomes", "code": { "@type": "MedicalCode", "code": "D009707", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Hitoshi Kurumizaka", "url": "https://questionsmedicales.fr/author/Hitoshi%20Kurumizaka", "affiliation": { "@type": "Organization", "name": "Laboratory of Chromatin Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan. Electronic address: kurumizaka@iam.u-tokyo.ac.jp." } }, { "@type": "Person", "name": "Karolin Luger", "url": "https://questionsmedicales.fr/author/Karolin%20Luger", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Vladimir B Teif", "url": "https://questionsmedicales.fr/author/Vladimir%20B%20Teif", "affiliation": { "@type": "Organization", "name": "School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK. vteif@essex.ac.uk." } }, { "@type": "Person", "name": "Felix Mueller-Planitz", "url": "https://questionsmedicales.fr/author/Felix%20Mueller-Planitz", "affiliation": { "@type": "Organization", "name": "Institute of Physiological Chemistry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. felix.mueller-planitz@tu-dresden.de." } }, { "@type": "Person", "name": "Guillaume Gaullier", "url": "https://questionsmedicales.fr/author/Guillaume%20Gaullier", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Prenatal diagnosis and genetic etiology analysis of talipes equinovarus by chromosomal microarray analysis.", "datePublished": "2023-11-20", "url": "https://questionsmedicales.fr/article/37986075", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12920-023-01733-2" } }, { "@type": "ScholarlyArticle", "name": "A Multicenter Analysis of Abnormal Chromosomal Microarray Findings in Congenital Heart Disease.", "datePublished": "2023-09-08", "url": "https://questionsmedicales.fr/article/37681527", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1161/JAHA.123.029340" } }, { "@type": "ScholarlyArticle", "name": "Prenatal Chromosomal Microarray Analysis: Does Increased Resolution Equal Increased Yield?", "datePublished": "2023-07-25", "url": "https://questionsmedicales.fr/article/37628571", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/genes14081519" } }, { "@type": "ScholarlyArticle", "name": "The Effect of Resolution Level and Targeted Design in the Diagnostic Performance of Prenatal Chromosomal Microarray Analysis.", "datePublished": "2023-08-07", "url": "https://questionsmedicales.fr/article/37549642", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000533137" } }, { "@type": "ScholarlyArticle", "name": "Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators.", "datePublished": "2023-11-11", "url": "https://questionsmedicales.fr/article/37951870", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12884-023-06052-z" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Phénomènes génétiques", "item": "https://questionsmedicales.fr/mesh/D055614" }, { "@type": "ListItem", "position": 3, "name": "Structures génétiques", "item": "https://questionsmedicales.fr/mesh/D040342" }, { "@type": "ListItem", "position": 4, "name": "Structures de chromosome", "item": "https://questionsmedicales.fr/mesh/D022004" }, { "@type": "ListItem", "position": 5, "name": "Chromatine", "item": "https://questionsmedicales.fr/mesh/D002843" }, { "@type": "ListItem", "position": 6, "name": "Nucléosomes", "item": "https://questionsmedicales.fr/mesh/D009707" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nucléosomes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nucléosomes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-27", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Nucléosomes", "description": "Comment identifier les nucléosomes dans une cellule ?\nQuels tests détectent les niveaux de nucléosomes ?", "url": "https://questionsmedicales.fr/mesh/D009707?mesh_terms=Microarray+Analysis#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Nucléosomes", "description": "Les nucléosomes sont-ils associés à des symptômes ?\nQuels troubles sont liés aux anomalies des nucléosomes ?", "url": "https://questionsmedicales.fr/mesh/D009707?mesh_terms=Microarray+Analysis#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Nucléosomes", "description": "Peut-on prévenir les anomalies des nucléosomes ?\nY a-t-il des dépistages pour les problèmes de nucléosomes ?", "url": "https://questionsmedicales.fr/mesh/D009707?mesh_terms=Microarray+Analysis#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Nucléosomes", "description": "Comment traiter les maladies liées aux nucléosomes ?\nLes médicaments ciblent-ils les nucléosomes ?", "url": "https://questionsmedicales.fr/mesh/D009707?mesh_terms=Microarray+Analysis#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Nucléosomes", "description": "Quelles complications peuvent survenir avec des nucléosomes anormaux ?\nLes nucléosomes affectent-ils la réparation de l'ADN ?", "url": "https://questionsmedicales.fr/mesh/D009707?mesh_terms=Microarray+Analysis#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Nucléosomes", "description": "Quels facteurs augmentent le risque d'anomalies des nucléosomes ?\nL'âge influence-t-il les nucléosomes ?", "url": "https://questionsmedicales.fr/mesh/D009707?mesh_terms=Microarray+Analysis#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier les nucléosomes dans une cellule ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les nucléosomes peuvent être identifiés par des techniques comme l'électrophorèse sur gel." } }, { "@type": "Question", "name": "Quels tests détectent les niveaux de nucléosomes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins mesurant les niveaux de nucléosomes libres sont utilisés en clinique." } }, { "@type": "Question", "name": "Les nucléosomes sont-ils associés à des symptômes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les nucléosomes eux-mêmes ne causent pas de symptômes, mais leur dysfonction peut être liée à des maladies." } }, { "@type": "Question", "name": "Quels troubles sont liés aux anomalies des nucléosomes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies des nucléosomes sont associées à des cancers et des maladies auto-immunes." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies des nucléosomes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation saine et un mode de vie actif peuvent réduire le risque de maladies associées." } }, { "@type": "Question", "name": "Y a-t-il des dépistages pour les problèmes de nucléosomes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de dépistage spécifique pour les anomalies des nucléosomes." } }, { "@type": "Question", "name": "Comment traiter les maladies liées aux nucléosomes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la maladie sous-jacente, incluant chimiothérapie ou immunothérapie." } }, { "@type": "Question", "name": "Les médicaments ciblent-ils les nucléosomes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments visent les voies de signalisation affectées par les nucléosomes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des nucléosomes anormaux ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des nucléosomes anormaux peuvent entraîner des cancers et des troubles immunitaires." } }, { "@type": "Question", "name": "Les nucléosomes affectent-ils la réparation de l'ADN ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans les nucléosomes peuvent perturber les mécanismes de réparation de l'ADN." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anomalies des nucléosomes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'exposition à des toxines et des prédispositions génétiques augmentent le risque." } }, { "@type": "Question", "name": "L'âge influence-t-il les nucléosomes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter la structure et la fonction des nucléosomes." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 04/03/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Hitoshi Kurumizaka

6 publications dans cette catégorie

Affiliations :
  • Laboratory of Chromatin Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan. Electronic address: kurumizaka@iam.u-tokyo.ac.jp.

Karolin Luger

4 publications dans cette catégorie

Publications dans "Nucléosomes" :

Vladimir B Teif

4 publications dans cette catégorie

Affiliations :
  • School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK. vteif@essex.ac.uk.

Felix Mueller-Planitz

3 publications dans cette catégorie

Affiliations :
  • Institute of Physiological Chemistry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. felix.mueller-planitz@tu-dresden.de.
Publications dans "Nucléosomes" :

Tomoya Kujirai

3 publications dans cette catégorie

Affiliations :
  • Laboratory of Chromatin Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.
Publications dans "Nucléosomes" :

Andrea Schmid

3 publications dans cette catégorie

Affiliations :
  • Biomedical Center (BMC), Molecular Biology, Faculty of Medicine, LMU Munich, Planegg-Martinsried, 82152 Munich, Germany.
Publications dans "Nucléosomes" :

Philipp Korber

3 publications dans cette catégorie

Affiliations :
  • Biomedical Center (BMC), Molecular Biology, Faculty of Medicine, LMU Munich, Planegg-Martinsried, 82152 Munich, Germany.
Publications dans "Nucléosomes" :

Ayako Furukawa

3 publications dans cette catégorie

Affiliations :
  • Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.

Yasuhiro Arimura

3 publications dans cette catégorie

Affiliations :
  • Laboratory of Chromatin Structure and Function, Institute for Quantitative Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

Yasuo Tsunaka

3 publications dans cette catégorie

Affiliations :
  • Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.

Yoshifumi Nishimura

3 publications dans cette catégorie

Affiliations :
  • Graduate School of Medical Life Science, Yokohama City University, 1-7-29 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
  • Graduate School of Integrated Sciences for Life, Hiroshima University, 1-4-4 Kagamiyama, Higashi-Hiroshima 739-8258, Japan.

Tae-Hee Lee

3 publications dans cette catégorie

Publications dans "Nucléosomes" :

Petra Vizjak

2 publications dans cette catégorie

Affiliations :
  • Institute of Physiological Chemistry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Department of Molecular Biology, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
  • Early Stage Bioprocess Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
Publications dans "Nucléosomes" :

Dieter Kamp

2 publications dans cette catégorie

Affiliations :
  • Gene Center, Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Publications dans "Nucléosomes" :

Nicola Hepp

2 publications dans cette catégorie

Affiliations :
  • Institute of Physiological Chemistry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Department of Molecular Biology, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
  • Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Publications dans "Nucléosomes" :

Alessandro Scacchetti

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biology, Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
  • Epigenetics Institute and Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publications dans "Nucléosomes" :

Mariano Gonzalez Pisfil

2 publications dans cette catégorie

Affiliations :
  • Core Facility Bioimaging and Walter-Brendel-Centre of Experimental Medicine, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried, Germany.
Publications dans "Nucléosomes" :

Joseph Bartho

2 publications dans cette catégorie

Affiliations :
  • Gene Center, Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
  • European Molecular Biology Laboratory, Heidelberg, Germany.
Publications dans "Nucléosomes" :

Mario Halic

2 publications dans cette catégorie

Affiliations :
  • Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Publications dans "Nucléosomes" :

Sources (10000 au total)

Prenatal diagnosis and genetic etiology analysis of talipes equinovarus by chromosomal microarray analysis.

With the advancement of molecular technology, fetal talipes equinovarus (TE) is believed to be not only associated with chromosome aneuploidy, but also related to chromosomal microdeletion and microdu... This retrospectively study included 131 fetuses with TE identified by ultrasonography. Conventional karyotyping and SNP array analysis were performed for all the subjects. They were divided into isola... Among the total of 131 fetuses, karyotype analysis found 12(9.2%) abnormal results, while SNP array found 27 (20.6%) cases. Trisomy 18 was detected most frequently among abnormal karyotypes. The detec... Fetal TE is related to chromosomal microdeletion or microduplication. Prenatal diagnosis is recommended for fetuses with TE, and CMA testing is preferred. CMA can improve the detection rate of chromos...

The Effect of Resolution Level and Targeted Design in the Diagnostic Performance of Prenatal Chromosomal Microarray Analysis.

This study was performed to assess the optimal resolution for prenatal testing by array comparative genomic hybridization (aCGH), aiming to balance between maximum diagnostic yield and minimal detecti... This was a prospective study using data of 2,336 fetuses that underwent invasive prenatal diagnosis, and the samples were analyzed by aCGH. In total, six different aCGH platforms were studied; four di... The diagnostic yield of copy number variants increased with increasing level of analysis. The detection rates of clinically significant chromosomal abnormalities were almost the same across our target... It appears that the targeted array platform with 0.5 Mb backbone resolution and 0.05 Mb on targeted gene-rich regions is optimal for routine chromosomal microarray analysis use in prenatal diagnosis. ...

Chromosome microarray analysis combined with karyotype analysis is a powerful tool for the detection in pregnant women with high-risk indicators.

Karyotype analysis and fluorescence in situ hybridization (FISH) are commonly used for prenatal diagnosis, however they have many disadvantages. Chromosome microarray analysis (CMA) has the potential ... A total of 3336 samples of amniotic fluid or umbilical cord blood from pregnant women with high-risk indicators at our center in southwest of China from June 2018 to January 2023 were included in the ... 3336 samples divided into 2911 cases with single and 425 cases with multiple high-risk indicators. The aneuploidy and pathogenic/likely pathogenic copy number variations (CNVs) of 2911 cases with sing... The combined application of CMA and karyotyping were recommended in prenatal diagnosis for providing a scientific and accurate genetic diagnosis and improving the quality of prenatal genetic counselin...

Fetal congenital gastrointestinal obstruction: prenatal diagnosis of chromosome microarray analysis and pregnancy outcomes.

The aim of this study was to investigate the incidence of chromosome anomalies in different types of congenital gastrointestinal obstruction and assess pregnancy outcomes of fetuses with congenital ga... A total of 64 cases with gastrointestinal obstruction between January 2014 and December 2020 were enrolled in this study. They were divided into three groups according to sonographic images. Group A: ... From January 2014 to December 2020, there were 64 fetus with congenital gastrointestinal obstruction underwent chromosome microarray analysis(CMA), the overall detection rate of CMA testing was 14.1%(... It is crucial to understand whether the gastrointestinal tract abnormality is isolated or associated to other findings. The risk of chromosomal abnormalities in fetuses with isolated lower gastrointes...

Prenatal diagnosis of chromosomal aberrations by chromosomal microarray analysis and pregnancy outcomes of fetuses with polyhydramnios.

To explore the prenatal clinical utility of chromosome microarray analysis (CMA) for polyhydramnios and evaluate the short and long-term prognosis of fetuses with polyhydramnios.... A total of 600 singleton pregnancies with persistent polyhydramnios from 2014 to 2020 were retrospectively enrolled in this study. All cases received amniocentesis and were subjected to CMA results. A... The detection rates of either aneuploidy or pathogenic copy number variants in fetuses with non-isolated polyhydramnios were significantly higher than those with isolated polyhydramnios (5.0... For low-risk pregnancies, invasive prenatal diagnosis of isolated polyhydramnios might be unnecessary. CMA should be considered for fetuses with structural anomalies. In CMA-negative cases, the progno...

Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathy.

Diabetic nephropathy (DN), which is the main cause of renal failure in end-stage renal disease, is becoming a common chronic renal disease worldwide. Mendelian randomization (MR) is a genetic tool tha... Five DN gene expression datasets were selected from the Gene Expression Omnibus. The robust rank aggregation (RRA) method was used to integrate differentially expressed genes (DEGs) of glomerular samp... A total of 82 DEGs (53 upregulated and 29 downregulated) were identified through RRA integrated analysis. The enriched Gene Ontology annotations and Kyoto Encyclopedia of Genes and Genomes pathways of... Our integrated analysis identified novel biomarkers, including MICB and GZMA, which may help further understand the complicated mechanisms of DN and identify new target pathways for intervention....

Identification of hub genes through integrated single-cell and microarray transcriptome analysis in osteoarthritic meniscus.

Osteoarthritis (OA) is marked by the progressive degradation of joint cartilage and subchondral bone. The precise molecular mechanisms driving meniscus deterioration in OA, especially at the single-ce... We analyzed two datasets from the GEO database, GSE220243 and GSE98918, focusing on meniscus tissue sequencing data from OA and non-OA patients. The standard Seurat procedure was employed to process s... After quality control, 34,763 cells from the OA patients and 34,145 cells from the healthy controls were analyzed. UMAP identified and SingleR annotated 14 cell clusters. The 10 largest cell clusters ... This research highlights crucial genes in the OA meniscus and uncovers their differing regulatory patterns between chondrocytes and non-chondrocytes. These findings enhance our understanding of the mo...